-
Table 1 shows the demographic characteristics of participants in the three surveys. The final sample sizes were 49, 233 in the 2002 survey (16, 828 in urban areas; 32, 405 in rural areas), 106, 673 in the 2010 survey (54, 016 in urban areas; 52, 657 in rural areas), and 179, 728 (73, 443 in urban areas; 106, 285 in rural area) in the 2015 survey. No statistical difference in genders was found among the three surveys.
Table 1. Demographic Characteristic Information of Participants in 2002, 2010, and 2015
In the 2002 survey, the mean age was 45.3 years (47.4 years in urban areas; 44.2 years in rural areas). Participants of Han descent accounted for 90.0% of the population (94.7% of the population in urban areas; 87.6% of the population in rural areas). Most participants completed junior or senior high school in urban areas; in rural areas, 50.2% of the participants attended primary school or below and only 2.6% had gone to college or above. The annual income of most participants was below 5, 000 RMB (44.7% in urban areas; 85.3% in rural areas).
The mean age in the 2010 survey was 52.0 years (50.5 years in urban areas; 52.3 years in rural areas) while that in the 2015 survey was 52.2 years (52.3 years in urban areas; 52.1 years in rural areas). An increasing trend of age was observed in the three surveys (P < 0.001). The number of participants with higher education levels and annual income significantly increased over the years (P < 0.001).
The total proportion of smokers was 26.6% (24.3% in urban areas; 27.7% in rural areas) in 2002, but no trend of smoking was observed among the three surveys. A significant decreasing trend of total proportion of drinkers from 22.3% in 2002 (23.1% in urban areas; 21.9% in rural areas) to 24.5% in 2010 (23.6% in urban area; 25.5% in rural areas) and then to 19.2% in 2015 (17.7% in urban areas; 20.0% in rural areas) (P < 0.001) was noted. By contrast, mean BMI showed a significant increasing trend from 23.2 kg/m2 in 2002 to 23.9 kg/m2 in 2010 and then to 24.2 kg/m2 in 2015 (P < 0.001). The proportions of low body weight (< 18.5 kg/m2), normal weight (18.5-23.9 kg/m2), overweight (24.0-27.9 kg/m2), and obese (≥ 28.0 kg/m2) participants significantly differed among the surveys (P < 0.001). Although the number of participants who had taken lipid control measures significantly increased from 2.4% in 2002 to 4.6% in 2010 and then to 4.5 in 2015 (P < 0.001), the overall proportion was still very low.
The trends of weighted adjustment Measurement of lipid control of lipid profiles among Chinese adults are demonstrated in Table 2. Total mean TC level and their 95% CIs significantly increased from 3.93 (3.87-3.99) mmol/L in 2002 to 4.59 (4.54-4.63) mmol/L in 2010 and then to 4.63 (4.59-4.67) mmol/L in 2015 (P < 0.001). Mean TG levels and their 95% CIs also significantly increased from 1.12 (1.10-1.15) mmol/L to 1.41 (1.39-1.44) mmol/L and then to 1.47 (1.45-1.50) mmol/L. However, mean HDL-c levels and their 95% CIs significantly decreased from 1.30 (1.28-1.31) mmol/L to 1.18 (1.16-1.20) mmol/L and then to 1.26 (1.24-1.27) mmol/L. Mean LDL-c levels and 95% CIs significantly increased from 2.12 (2.08-2.17) mmol/L to 2.78 (2.75-2.82) mmol/L and then to 2.87 (2.84-2.90) mmol/L (P < 0.001). Between the 2002 and 2010 surveys, mean levels of lipids, such as TC, TG and LDL-c, were higher in urban areas than in rural areas, but HDL-c concentrations were similar. However, in the 2015 surveys, TG and LDL-c levels were higher in urban areas than in rural areas; moreover, TC levels between urban and rural areas differed but HDL-c levels were higher in rural areas than in urban area. TG levels were much higher in males than in females in all three surveys. Increasing trends of TC, TG, and LDL-c levels were observed in males from 2002 to 2015; in females, the change in HDL-c was not significant. TC, TG, and LDL-c levels almost increased significantly with increasing age; in the 75-year-old group, a slight fluctuation of HDL-c level with no significant difference was observed during the period. Longitudinally, regardless of area, gender, or BMI, TC, TG, and LDL-c levels consistently increased whereas HDL-c levels decreased from 2002 to 2015 (P < 0.001). Weighted adjusted means of non-HDL-c levels in Table 3 showed an increasing trend in all age groups and both genders. An increasing trend of mean non-HDL-c levels was observed in urban and rural areas from 2002 to 2015. Similarly, the ratios of TC/HDL-c, TG/HDL-c, and LDL-c/HDL-c showed increasing trends among all genders, districts, ages, and BMIs (P < 0.001).
Table 2. Lipids Profiles among Participants in Survey 2002, 2010, and 2015 [mean (95% CI)]
Table 3. Non-HDL-c and Lipid-related Ratios among Participants in Survey 2002, 2010, and 2015 [mean (95% CI)]
Figure 2 shows the prevalence of dyslipidemia among Chinese adults from 2002 to 2015. The total weighted adjusted prevalence of hypercholesterolemia was 1.6% (95% CI: 1.3%-1.8%) in 2002, increased to 5.6% (95% CI: 5.1%-6.1%) in 2010, and then increased to 5.8% (95% CI: 5.3%-6.3%) in 2015 (P for trend < 0.001). Hypertriglyceridemia prevalence dramatically increased from 5.7% (95% CI: 5.1%-6.3%) to 13.6% (95% CI: 12.9%-14.2%) and then to 15.0% (95% CI: 14.3%-15.7%). Low HDL-c prevalence changed remarkably over these years, increasing from 18.8% (95% CI: 17.0%-20.6%) to 35.5% (95% CI: 33.3%-37.6%) and then to 24.9% (95% CI: 23.5%-26.4%). Similarly, LDL-c prevalence increased from 1.3% to 5.6% and then to 7.2% over the 13-year interval. Among urban and rural participants, the prevalence of hypercholesterolemia were much higher in the former than in the latter in the 2002 and 2010 surveys; however, in 2015, hypercholesterolemia prevalence was slightly higher in rural areas than in urban areas. Furthermore, in 2002, hypercholesterolemia prevalence was higher in females than in males, and it increased from 0.7% in the 18-year-old group to 3.4% in the 65-year-old group but then decreased to 2.7% in the 75-year-old group. Similar distributions of hypercholesterolemia were observed in the 2010 and 2015 surveys. From a longitudinal perspective, the prevalence of hypercholesterolemia from 2002 to 2015 remarkably increased in rural areas from 1.0% to 4.4% and then to 6.2%; interestingly, however, this prevalence in urban areas increased from 2.0% to 6.3% but then declined to 5.3%. About high LDL-c similar results with hypercholesterolemia was observed in both urban and rural areas, as well as in all genders, age groups, and BMI groups. However, hypertriglyceridemia prevalence was higher in males than in females, higher in urban areas than in rural areas, and higher in middle-aged adults than in their elderly counterparts. Longitudinally, an increasing trend of hypertriglyceridemia prevalence could be observed from 2002 to 2015. Low HDL-c prevalence was much higher in the dyslipidemia type. Moreover, HDL-c prevalence was higher in rural areas than in urban areas in 2002, while this prevalence was similar between areas in 2010 and then higher in urban areas than in rural areas in 2015. Interestingly, in the age groups of 55 years and above, the trends of low HDL-c prevalence were not statistically significant among the three survey years.
doi: 10.3967/bes2019.074
-
Abstract:
Objective To investigate the trends of lipid profiles and dyslipidemia among Chinese adults from 2002 to 2015. Methods Data were collected from three nationally representative cross-sectional surveys. Fasting venous blood samples were collected and serum lipids were tested by biochemical analysis and enzymatic determination. Lipid levels and the prevalence of dyslipidemia among adults were analyzed with complex sampling weighting adjustment for age and gender. Results The weighted means of TC, TG, and LDL-c significantly increased linearly from 3.93, 1.12, and 2.12 mmol/L in 2002 to 4.59, 1.41, and 2.78 mmol/L in 2010 and then to 4.63, 1.47, and 2.87 mmol/L in 2015, respectively; by contrast, HDL-c levels decreased significantly from 1.30 mmol/L to 1.26 mmol/L over the same period. Similar trends in mean non-HDL-c and lipid-related ratios were observed. The weighted dyslipidemia prevalence linearly increased; in particular, hypercholesterolemia increased from 1.6% to 5.6% and then to 5.8%, hypertriglyceridemia increased from 5.7% to 13.6% and then to 15.0%, low HDL-c increased from 18.8% to 35.5% and then to 24.9%, and high LDL-c increased from 1.3% to 5.6% and then to 7.2% (P for trend < 0.001). Conclusion Dyslipidemia increased among Chinese adults from 2002 to 2015. Development of a comprehensive strategy to decrease lipid levels in this population is urgently required. -
Key words:
- Lipids /
- Dyslipidemia /
- Cross-sectional study /
- Adults /
- China
-
Table 1. Demographic Characteristic Information of Participants in 2002, 2010, and 2015
Table 2. Lipids Profiles among Participants in Survey 2002, 2010, and 2015 [mean (95% CI)]
Table 3. Non-HDL-c and Lipid-related Ratios among Participants in Survey 2002, 2010, and 2015 [mean (95% CI)]
-
[1] Moran A, Gu D, Zhao D, et al. Future cardiovascular disease in china:Markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes, 2010; 3, 243-52. doi: 10.1161/CIRCOUTCOMES.109.910711 [2] Force M, Catapano AL, Graham I, et al. 2016 esc/eas guidelines for the management of dyslipidaemias:The task force for the management of dyslipidaemias of the european society of cardiology (esc) and european atherosclerosis society (eas) developed with the special contribution of the european assocciation for cardiovascular prevention & rehabilitation (eacpr). Atherosclerosis, 2016; 253, 281-344. doi: 10.1016/j.atherosclerosis.2016.08.018 [3] Rosenberg K. High ldl-c, non-hdl-c levels associated with higher cvd death risk, even in those at low cvd risk. Am J Nurs, 2018; 118, 67. http://www.onacademic.com/detail/journal_1000041622544999_8f6b.html [4] Wang K, Shan S, Zheng H, et al. Non-hdl-cholesterol to hdl-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-hdl-cholesterol:A cohort study. Lipids Health Dis, 2018; 17, 196. doi: 10.1186/s12944-018-0848-8 [5] Yokoyama K, Tani S, Matsuo R, et al. Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size:Assessment of atherosclerotic cardiovascular disease risk. Heart Vessels, 2019; 34, 227-36. doi: 10.1007/s00380-018-1247-9 [6] Song PK, Li H, Man QQ, et al. Trends in determinants of hypercholesterolemia among chinese adults between 2002 and 2012:Results from the national nutrition survey. Nutrients, 2017; 9, 279. doi: 10.3390/nu9030279 [7] Joint committee for the revision of guidelines for the prevention and treatment of dyslipidemia in Chinese adults. Guidelines for the prevention and treatment of dyslipidemia in chinese adults (2016 revision). Chinese Circulation Journal, 2016; 31, 937-53. (In Chinese) [8] National Bureau of Statistics. Tabulation on the 2010 population census of the people's republic of china. China Statistics Press, Beijing, 2012. [9] Carroll MD, Lacher DA, Sorlie PD, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA, 2005; 294, 1773-81. doi: 10.1001/jama.294.14.1773 [10] Ferrieres J, Bongard V, Dallongeville J, et al. Trends in plasma lipids, lipoproteins and dyslipidaemias in french adults, 1996-2007. Arch Cardiovasc Dis, 2009; 102, 293-301. doi: 10.1016/j.acvd.2009.02.002 [11] Cohen JD, Cziraky MJ, Cai Q, et al. 30-year trends in serum lipids among United States adults:results from the National Health and Nutrition Examination Surveys Ⅱ, Ⅲ, and 1999-2006. Am J Cardiol, 2010; 106, 969-75. doi: 10.1016/j.amjcard.2010.05.030 [12] Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980:Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet, 2011; 378, 31-40. doi: 10.1016/S0140-6736(11)60679-X [13] Carroll MD, Kit BK, Lacher DA, et al. Trends in lipids and lipoproteins in us adults, 1988-2010. Jama, 2012; 308, 1545-54. doi: 10.1001/jama.2012.13260 [14] Okamura T. Dyslipidemia and cardiovascular disease:A series of epidemiologic studies in japanese populations. J Epidemiol, 2010; 20, 259-65. doi: 10.2188/jea.JE20100060 [15] Mercado CI, Gregg E, Gillespie C, et al. Trends in lipid profiles and descriptive characteristics of U. S. adults with and without diabetes and cholesterol-lowering medication use-national health and nutrition examination survey, 2003-2012, United States. PloS One, 2018; 13, e0193756. doi: 10.1371/journal.pone.0193756 [16] Ahmed F, Waslien C, Al-Sumaie M, et al. Trends and risk factors of hypercholesterolemia among Kuwaiti adults:National Nutrition Surveillance Data from 1998 to 2009. Nutrition, 2014; 28, 917-23. http://www.sciencedirect.com/science/article/pii/S0899900712000056 [17] Baghbani-Oskouei A, Tohidi M, Asgari S, et al. Serum Lipids during 20 years in the Tehran Lipid and Glucose Study:Prevalence, trends and impact on non-communicable diseases. Int J Endocrinol Metab, 2018; 16, e84750. [18] Zaid M, Hasnain S. Plasma lipid abnormalities in Pakistani population:trends, associated factors, and clinical implications. Braz J Med Biol Res. 2018; 51, e7239. https://www.onacademic.com/detail/journal_1000040509475810_cd36.html [19] Nejat A, Mirbolouk M, Mohebi R, et al. Changes in lipid measures and incident coronary heart disease:Tehran lipid & glucose study. Clin Biochem, 2014; 47, 1239-44. doi: 10.1016/j.clinbiochem.2014.03.004 [20] Zhao WH, Zhang J, Zhai Y, et al. Blood lipid profile and prevalence of dyslipidemia in chinese adults. Biomed Environ Sci, 2007; 20, 329-35. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=bes200704013 [21] Nakamura Y, Okuda N, Turin TC, et al. Fatty acids intakes and serum lipid profiles:NIPPON DATA90 and the national nutrition monitoring. J Epidemiol, 2010; 20, S544-8. doi: 10.2188/jea.JE20090223 [22] Kong C, Nimmo L, Elatrozy T, et al. Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis, 2001; 156, 373-8. doi: 10.1016/S0021-9150(00)00664-X [23] Wood AM, Kaptoge S, Butterworth AS, et al. Risk thresholds for alcohol consumption:combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet, 2018; 391, 1513-23. doi: 10.1016/S0140-6736(18)30134-X [24] Joshi SR, Anjana RM, Deepa M, et al. Prevalence of dyslipidemia in urban and rural India:the ICMR-INDIAB study. PLoS One, 2014; 9, e96808. doi: 10.1371/journal.pone.0096808 [25] Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity:mechanisms and potential targets. Nutrient, 2013; 5, 1218-40. doi: 10.3390/nu5041218 [26] Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease:A scientific statement from the american heart association. Circulation, 2011; 123, 2292-333. doi: 10.1161/CIR.0b013e3182160726 [27] Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet, 2014; 384, 626-35. doi: 10.1016/S0140-6736(14)61177-6 [28] Chapman MJ, Ginsberg HN, Amarenco P, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease:evidence and guidance for management. Eur Heart J, 2011; 32, 1345-61. doi: 10.1093/eurheartj/ehr112 [29] Huang Y, Gao L, Xie X, et al. Epidemiology of dyslipidemia in chinese adults:Meta-analysis of prevalence, awareness, treatment, and control. Popul Health Metr, 2014; 12, 28. doi: 10.1186/s12963-014-0028-7 [30] Pan L, Yang Z, Wu Y, et al. The prevalence, awareness, treatment and control of dyslipidemia among adults in china. Atherosclerosis, 2016; 248, 2-9. doi: 10.1016/j.atherosclerosis.2016.02.006 [31] Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment:prospectivemeta-analysis of data from 90, 056 participants in 14 randomised trials ofstatins. Lancet, 2005; 366, 1267-78. doi: 10.1016/S0140-6736(05)67394-1 [32] Nicholls SJ, Brandrup-Wognsen G, Palmer M, et al. Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER). Am J Cardiol, 2010; 105, 69-76. doi: 10.1016/j.amjcard.2009.08.651 [33] Kong SH, Koo BK, Moon MK. Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus. Diabetes Metab J, 2017; 41, 23-30. doi: 10.4093/dmj.2017.41.1.23 [34] Otsuka T, Mizuno K, Shinozaki T, et al. Preventive effect of pravastatin on the development of hypertension in patients with hypercholesterolemia:A post-hoc analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study. J Clin Lipidol, 2017; 11, 998-1006. doi: 10.1016/j.jacl.2017.05.015 [35] Ang J, Li LJ, He YC, et al. An exploring study on the pharmacodynamics of rosuvastatin in Chinese hypercholesterolemic patients. Chin J Clin Pharm Ther, 2010; 15, 894-900. http://d.old.wanfangdata.com.cn/Periodical/zglcylxyzlx201008012 [36] Zhao S, Peng D. Efficacy and safety of rosuvastatin versus atorvastatin in high-risk Chinese patients with hypercholesterolemia:a randomized, double-blind, active-controlled study. Curr Med Res Opin, 2018; 34, 227-35. doi: 10.1080/03007995.2017.1371584 [37] Wu LX. Efficacy and safety of rosuvastatin in aged patients with coronary heart disease and hypercholesterolemia. Chin Mod Med, 2013; 20, 70-1. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhongguoyy201107003 [38] Li JH, Wang LM, Mi SQ, et al. Awareness rate, treatment rate and control rate of dyslipidemia in chinese adults, 2010. Chin J Prev Med, 2012; 46, 687-91. (In Chinese) http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyfyx201208004 [39] Song P, Zha M, Yang X, et al. Socioeconomic and geographic variations in the prevalence, awareness, treatment and control of dyslipidemia in middle-aged and older chinese. Atherosclerosis, 2019; 282, 57-66. (In Chinese) doi: 10.1016/j.atherosclerosis.2019.01.005 [40] Zhang FL, Xing YQ, Wu YH, et al. The prevalence, awareness, treatment, and control of dyslipidemia in northeast china:A population-based cross-sectional survey. Lipids Health Dis, 2017; 16, 61. doi: 10.1186/s12944-017-0453-2